1![TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS REPORT BY THE DECISION SUPPORT UNIT Stephen Palmer, Mark Sculpher TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS REPORT BY THE DECISION SUPPORT UNIT Stephen Palmer, Mark Sculpher](https://www.pdfsearch.io/img/f6c30a434cb3bf9a1e13bafcf613ddac.jpg) | Add to Reading ListSource URL: www.nicedsu.org.uk- Date: 2010-08-10 09:30:26
|
---|
2![NOVEMBER 2015 TABLE OF CONTENTS INTRODUCTION NOVEMBER 2015 TABLE OF CONTENTS INTRODUCTION](https://www.pdfsearch.io/img/b72c75c50a30f5969f8c3e44958e81c3.jpg) | Add to Reading ListSource URL: www.abirisk.euLanguage: English - Date: 2016-03-04 10:05:54
|
---|
3![TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS](https://www.pdfsearch.io/img/ffdd0312975a0ed38a7c329e2e4a9bc8.jpg) | Add to Reading ListSource URL: www.nicedsu.org.ukLanguage: English |
---|
4![JULY 2016 TABLE OF CONTENTS INTRODUCTION JULY 2016 TABLE OF CONTENTS INTRODUCTION](https://www.pdfsearch.io/img/77aacceb3e8c1c92d5a153550d4f4910.jpg) | Add to Reading ListSource URL: www.abirisk.euLanguage: English - Date: 2016-07-28 12:58:50
|
---|
5![TABLE OF CONTENTS INTRODUCTION 2 TABLE OF CONTENTS INTRODUCTION 2](https://www.pdfsearch.io/img/f9c9f308c7929b58d8cb066c06549e7f.jpg) | Add to Reading ListSource URL: www.abirisk.euLanguage: English - Date: 2015-06-19 09:17:30
|
---|
6![Important Safety Information for Infectious Disease Specialists About Potential Risks of Infections With ACTEMRA® ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist that has been approved by the Food Important Safety Information for Infectious Disease Specialists About Potential Risks of Infections With ACTEMRA® ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist that has been approved by the Food](https://www.pdfsearch.io/img/2d6360f110474b52efa40c890d39dae8.jpg) | Add to Reading ListSource URL: www.actemrahcp.com- Date: 2015-06-26 19:54:25
|
---|
7![Important Safety Information for Emergency Medicine Physicians About Potential Risks of Infection and Gastrointestinal Perforation With ACTEMRA® ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist tha Important Safety Information for Emergency Medicine Physicians About Potential Risks of Infection and Gastrointestinal Perforation With ACTEMRA® ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist tha](https://www.pdfsearch.io/img/a294289c71bb9a187156a0e9eda73dce.jpg) | Add to Reading ListSource URL: www.actemrahcp.com- Date: 2015-06-09 08:47:12
|
---|
8![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ACTEMRA safely and effectively. See full prescribing information for ACTEMRA. ACTEMRA® (tocilizumab) Injection, for HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ACTEMRA safely and effectively. See full prescribing information for ACTEMRA. ACTEMRA® (tocilizumab) Injection, for](https://www.pdfsearch.io/img/5dcec507436b6d43c81998c5c0baec11.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2010-01-12 14:41:46
|
---|
9![Important Safety Information for Rheumatologists About Risks in Patients Receiving ACTEMRA® ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist that has been approved by the Food and Drug Administrati Important Safety Information for Rheumatologists About Risks in Patients Receiving ACTEMRA® ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist that has been approved by the Food and Drug Administrati](https://www.pdfsearch.io/img/4f7880dfcbec6599287c9ea3ec43a4c0.jpg) | Add to Reading ListSource URL: www.actemrahcp.comLanguage: English - Date: 2015-06-21 12:11:52
|
---|
10![Important Safety Information for Gastroenterologists and Hepatologists About Potential Risks of Gastrointestinal Perforation and Transaminase Elevations With ACTEMRA® ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) r Important Safety Information for Gastroenterologists and Hepatologists About Potential Risks of Gastrointestinal Perforation and Transaminase Elevations With ACTEMRA® ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) r](https://www.pdfsearch.io/img/ebb93af612f9838fc7b5a2debf5bcc91.jpg) | Add to Reading ListSource URL: www.actemrahcp.comLanguage: English - Date: 2015-06-13 09:31:41
|
---|